Dr Stock Pick HOT News & Alerts!

_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Wednesday October 28, 2009

DrStockPick.com Stock Report!

CSRH, EXC, PSFT, DB, PWRM, AVP, AQNM, RF, CVAT, LMT

**************************************************************

EXC, Exelon Corp.

EXC, a utility services holding company, through its subsidiaries, engages in the generation, transmission, distribution, and sale of electricity to residential, commercial, industrial, and wholesale customers in northern Illinois.

The Board of Directors of EXC declared a regular quarterly dividend of $0.525 per share on Exelon’s common stock. The dividend is payable on December 10, 2009, to shareholders of record of Exelon at 5:00 p.m. New York Time on November 13, 2009.

**************************************************************

PSFT, Powersafe Technology Corp., PSFT.PK

PSFT subsidiary Amplification Technologies Inc. (www.amplificationtechnologies.com)

It is a gray morning, here in London. We sit in the building with the golden balls, look out the window, and wonder…

…how does it all work?

We’re doing some serious thinking this week. What is it that actually causes a depression? A stock market collapse? Or too much debt? How come government can appear to cure the problem sometimes – 2001-2007 – but not other times? How come the Japanese were not able to increase consumer prices? Even now… Japan’s inflation rate is negative. And how come, despite the most massive effort at monetary inflation ever undertaken, the US bond market still forecasts an inflation rate of less than 2%?

An interview with Richard Koo, author of ‘The Balance Sheet Recession,’ and a new book by Ken Rogoff and Carmen Reinhart are helping us understand what it going on. More to come…

In the meantime, the Dow went down 42 points

Provectus Pharmaceuticals, Inc.

(Public, OTC:PVCT)

StocksHaven Investments profiles one of the most exciting up-and-coming anti-cancer companies in the industry, Provectus Pharmaceuticals (OTC:PVCT). They have one of the deepest pipelines of any small cap biotech, focusing on treatments for: Melanoma, Psoriasis, Atopic Dermatitis, Breast Cancer, and Liver Metastasis. With three drugs nearly ready to enter Phase III, including one nearly entering Phase II for Breast Cancer, one of the largest target markets worldwide and seeking “compassionate use” in Australia and USA, look for Provectus to make a splash within the next couple of months.

They are developing and testing one of the most exciting anti- cancer compounds. It has been demonstrating significant effectiveness against Melanoma in Phase 2 clinical trials and it offers promising treatment for breast, liver and other solid tumor based metastatic cancers. The compound developed by Provectus, known as PV-10, is a

According to media reports from China, an insider revealed that Chinese actress Zhao Wei registered her marriage in Singapore a few days ago with a Singaporean businessman, and will hold her wedding dinner in October this year. Zhao Wei’s manager denied the reports and pointed out that Zhao is currently held up with work and will not be getting married in the near future.

The 33-year-old actress has been plagued with rumours ever since her debut in the entertainment industry. She was once speculated to have been involved with actors Chen Kun and Huang Xiao Ming. Earlier this month, Zhao openly declared her intentions to temporarily leave the entertainment circle to concentrate on her studies after the completion of the film Hua Mulan’s promotional events.

However, insiders discovered and exposed Zhao’s original intentions for a temporary departure for her own marriage plans. She is said to be registered to a Singaporean